MarginsXMarginsX
Home › Markets › Health Care › PFSA

Profusa Inc. (PFSA)

PFSA trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$0.4057
-9.44% on the day
Market cap
$246K
Nano cap
Revenue · 2024
$100K
No prior year to compare
Net income · 2024
-$9.2M
-9230.0% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:Revenues), fiscal year ended 2024-12-31, https://www.sec.gov/Archives/edgar/data/1859807/000121390026044046/0001213900-26-044046-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2024-12-31.

Profile

FieldValue
TickerPFSA on Nasdaq
SectorHealth Care
IndustryMedical/Dental Instruments
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0001859807
SEC industry codeSurgical & Medical Instruments & Apparatus
Incorporated inDE

Financials · 2024

LineValue
Revenue$100K
Net income-$9.2M
Operating income-$4.5M
Net margin-9230.0%
Operating margin-4500.0%
Revenue growthNo prior-year revenue to compare
Cash$191K
Total assets$3.1M
P/E (computed)Net income was not positive
P/S (computed)2.5×

Warning signs

Cash runway
0.4 months
$719K cash at June 30, 2026
Share count, 1 year
+64781.2%
2025-11-18 to 2026-11-13 · +690811.4% over 3 years
Going-concern doubt
Yes
10-Q filed November 13, 2026
Insider net buying, 12 months
-$116K
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"As of September 30, 2026, there continue to be factors which raise substantial doubt about the Company's ability to continue as a going concern within one year from the date the condensed consolidated financial statements are issued."
10-Q 2026-11-13
Cash and burn$719K cash; operating cash flow -$5.1M a quarter.Report 2026-06-30
Shares outstanding5,681,947 (2026-11-13); 65,680,958 a year earlier; 6,167,882 three years earlier. 1y figure adjusted for splits (1-for-7500 overall); 3y figure adjusted for splits (1-for-7500 overall).Cover page 2026-11-13
Reverse splits, 3 years3; latest 1-for-4 on 2026-08-17Source 2026-08-17
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 months3 (8-K item 3.01)8-K 2026-08-31
Delisting25-NSE filed25-NSE 2025-05-22
AuditorCBIZ CPAs P.C., San Francisco, California, United States; changed auditors 2 times in 24 months8-K 4.01 2026-10-09
Late filings, 12 months2 NT noticesNT 10-Q 2026-08-14
Insider trades, 12 monthsBought $37K, sold $153K on the open marketSEC Forms 3/4/5 data sets 2026-09-30
Market cap checkThe listing's market cap implies 605,647 shares at the 2026-11-13 price; the latest SEC cover count is 5,681,947 as of 2026-11-13. One of the two share counts is stale.Nasdaq screener and SEC cover page

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2026
2026-06-30
Not filed-$8.8M-$2.6M$719K$17.0MNeeds four quarters10-Q 2026-08-19
Q1 2026
2026-03-31
Not filed-$3.5M-$2.6M$375K$16.6MNeeds four quarters10-Q 2026-08-19
Q4 2025
2025-12-31
Not filed-$8.6M-$5.1M$1.8M$10.8MNeeds four quarters10-K 2026-04-15
Q3 2025
2025-09-30
Not filed-$22.2M-$10.0M$3.0M$19.7MNeeds four quarters10-Q 2025-11-19
Q2 2025
2025-06-30
Not filed-$2.3M-$589K$39K$1.9MNeeds four quarters10-Q 2026-08-19
Q1 2025
2025-03-31
Not filed-$2.7M-$537K$19K$3.4MNeeds four quarters10-Q 2026-08-19
Q4 2024
2024-12-31
$0-$2.3M-$238K$191K$48.8M$100K10-K 2026-04-15
Q3 2024
2024-09-30
$75K-$2.5M-$1.2M$533$3.4MNeeds four quarters10-Q 2025-11-19

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
PROSPECTUS SUPPLEMENT
424B32026-07-07
Latest annual report
ANNUAL REPORT
10-K2026-04-15
Latest quarterly / interim
QUARTERLY REPORT
10-Q2026-11-13
Latest current report
CURRENT REPORT
8-K2026-11-06
Latest proxy
PROXY STATEMENT
PRE 14A2026-11-10

Source: SEC EDGAR submissions feed, 326 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-16.1%
1 month-65.0%
3 months-88.2%
Year to date-99.9%
1 year-100.0%
From 52-week high-100.0%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
VJETFlyte Aviation Inc.$0.4430-10.11%$931K
NXGLNexGel Inc$3.93+2.08%$1.9M
AMIXAutonomix Medical Inc.$1.10-19.71%$2.2M
CODXCo-Diagnostics Inc.$0.2249-13.03%$2.4M
BJDXBluejay Diagnostics Inc.$2.29-12.26%$2.6M
ICCMIceCure Medical Ltd.$0.7601+4.12%$2.6M
IVFINVO Fertility Inc.$2.40-7.69%$2.8M
VVOSVivos Therapeutics Inc.$0.0822-16.12%$2.8M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier